Several leading firms worldwide focus on the manufacture of complex medicinal APIs, notably Abacavir sulfate, Abarelix, and Abiraterone Acetate. These compounds present significant hurdles in process development due to their chemical intricacy. The producers of these APIs often employ specialized technologies and adhere to strict regulatory protoco